Who Says Cancer Patients are Worthless?

Those of us who have experienced life-threatening illnesses or chronic health conditions are used to putting up with challenges and frustrations that people in perfect health don’t have to deal with. However, no matter what disease might challenge us, we don’t...

Amgen’s Right, ICER Cherry Picks Who Lives Or Dies

A lot of the health media was surprised that Amgen decided to criticize ICER before it released its draft decision about the price and access to new medicines for multiple myeloma including Amgen’s Kyprolis. I wasn’t.  After all, Amgen had already dealt...